Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Aaron Schimmer Sara Farshchi Zarabi |
| Publication date | June 9, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |